Naturally occurring pentacyclic triterpenes as inhibitors of glycogen phosphorylase: Synthesis, structure-activity relationships, and X-ray crystallographic studies

被引:188
|
作者
Wen, Xiaoan [1 ]
Sun, Hongbin [1 ]
Liu, Jun [2 ]
Cheng, Keguang [1 ]
Zhang, Pu [1 ]
Zhang, Liying [1 ]
Hao, Jia [1 ]
Zhang, Luyong [2 ]
Ni, Peizhou [1 ]
Zographos, Spyros E. [3 ]
Leonidas, Demetres D. [3 ]
Alexacou, Kyra-Melinda [3 ]
Gimisis, Thanasis [4 ]
Hayes, Joseph M. [3 ]
Oikonomakos, Nikos G. [3 ]
机构
[1] China Pharmaceut Univ, Coll Pharm, Ctr Drug Discovery, Nanjing 210009, Peoples R China
[2] China Pharmaceut Univ, Jiangsu Ctr Drug Screening, Nanjing 210038, Peoples R China
[3] Natl Hellen Res Fdn, Inst Organ & Pharmaceut Chem, Athens 11635, Greece
[4] Univ Athens, Dept Chem, Organ Chem Lab, Athens 15771, Greece
关键词
D O I
10.1021/jm8000949
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Twenty-five naturally occurring pentacyclic triterpenes, 15 of which were synthesized in this study, were biologically evaluated as inhibitors of rabbit muscle glycogen phosphorylase a (GPa). From SAR studies, the presence of a sugar moiety in triterpene saponins resulted in a markedly decreased activity (7, 18-20) or no activity (21, 22). These saponins, however, might find their value as potential natural prodrugs which are much more water-soluble than their corresponding aglycones. To elucidate the mechanism of GP inhibition, we have determined the crystal structures of the GPb-asiatic acid and GPb-maslinic acid complexes. The X-ray analysis indicates that the inhibitors bind at the allosteric activator site, where the physiological activator AMP binds. Pentacyclic triterpenes represent a promising class of multiple-target antidiabetic agents that exert hypoglycemic effects, at least in part, through GP inhibition.
引用
收藏
页码:3540 / 3554
页数:15
相关论文
共 50 条
  • [41] Synthesis, structure-activity relationships and molecular docking studies of phenyldiazenyl sulfonamides as aromatase inhibitors
    Giampietro, Letizia
    Gallorini, Marialucia
    Gambacorta, Nicola
    Ammazzalorso, Alessandra
    De Filippis, Barbara
    Della Valle, Alice
    Fantacuzzi, Marialuigia
    Maccallini, Cristina
    Mollica, Adriano
    Cataldi, Amelia
    Nicolotti, Orazio
    Amoroso, Rosa
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 224
  • [42] Structure-activity relationships(SAR) studies of CamK II inhibitors
    Kieres, Karolina
    Sala, Marina
    Monterrey, Gomez Isabel
    Bertamino, Alessia
    D'Ursi, Annamaria
    Ilario, Maddalena
    Grieco, Paolo
    Novellino, Ettore
    Campiglia, Pietro
    JOURNAL OF PEPTIDE SCIENCE, 2008, 14 (08) : 87 - 87
  • [43] Synthesis and structure-activity relationships of benzophenones as inhibitors of cathepsin D
    Whitesitt, CA
    Simon, RL
    Reel, JK
    Sigmund, SK
    Phillips, ML
    Shadle, JK
    Heinz, LJ
    Koppel, GA
    Hunden, DC
    Lifer, SL
    Berry, D
    Ray, J
    Little, SP
    Liu, XD
    Marshall, WS
    Panetta, JA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (18) : 2157 - 2162
  • [44] Cysteine derivatives as inhibitors for carboxypeptidase A: Synthesis and structure-activity relationships
    Park, JD
    Kim, DH
    JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (04) : 911 - 918
  • [45] Synthesis and structure-activity relationships of novel benzofuran farnesyltransferase inhibitors
    Asoh, Kohsuke
    Kohchi, Masami
    Hyoudoh, Ikumi
    Ohtsuka, Tatsuo
    Masubuchi, Miyako
    Kawasaki, Kenichi
    Ebiike, Hirosato
    Shiratori, Yasuhiko
    Fukami, Takaaki A.
    Kondoh, Osamu
    Tsukaguchi, Toshiyuki
    Ishii, Nobuya
    Aoki, Yuko
    Shimma, Nobuo
    Sakaitani, Masahiro
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (06) : 1753 - 1757
  • [46] Design, synthesis and structure-activity relationships of novel ALS inhibitors
    Ren, TR
    Yang, HW
    Gao, X
    Yang, XL
    Zhou, JJ
    Cheng, FH
    PEST MANAGEMENT SCIENCE, 2000, 56 (03) : 218 - 226
  • [47] Synthesis and Quantitative Structure-Activity Relationships of Selective BCRP Inhibitors
    Marighetti, Federico
    Steggemann, Kerstin
    Hanl, Markus
    Wiese, Michael
    CHEMMEDCHEM, 2013, 8 (01) : 125 - 135
  • [48] X-RAY ANALYSES AND STRUCTURE-ACTIVITY RELATIONS OF ANTIPROGESTINS
    HERRMANN, C
    HOYER, GA
    NEEF, G
    SCHOMBURG, D
    WIECHERT, R
    LIEBIGS ANNALEN DER CHEMIE, 1986, (08): : 1317 - 1326
  • [49] Oxazolones: New tyrosinase inhibitors; synthesis and their structure-activity relationships
    Khan, Khalid Mohammed
    Mughal, Uzma Rasool
    Khan, Mahmud Tareq Hassan
    Zia-Ullah
    Perveen, Shahnaz
    Choudhary, Muhammad Iqbal
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (17) : 6027 - 6033
  • [50] X-Ray crystallographic studies of rationally designed dihydroorotate dehydrogenase inhibitors
    Acklam, Paul
    Bedingfield, Paul
    Cunningham, Fraser
    Cowen, Deborah
    McConkey, Glenn
    Fishwick, Colin
    Johnson, Peter
    Parsons, Mark
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2011, 67 : C312 - C312